Join Growin Stock Community!

Kewaunee scientific corporationKEQU.US Overview

US StockConsumer Cyclical
(No presentation for KEQU)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

KEQU AI Insights

KEQU Overall Performance

KEQU AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

KEQU Recent Performance

0.31%

Kewaunee scientific corporation

-1.91%

Avg of Sector

-0.31%

S&P500

KEQU PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

KEQU Key Information

KEQU Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

KEQU Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

Price of KEQU

KEQU FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

KEQU Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.10
PE Ratio (TTM)
9.70
Forward PE
-
PS Ratio (TTM)
0.42
PB Ratio
1.69
Price-to-FCF
23.37
METRIC
VALUE
vs. INDUSTRY
Gross Margin
29.09%
Net Margin
4.11%
Revenue Growth (YoY)
43.02%
Profit Growth (YoY)
56.41%
3-Year Revenue Growth
8.71%
3-Year Profit Growth
31.35%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.10
PE Ratio (TTM)
9.70
Forward PE
-
PS Ratio (TTM)
0.42
PB Ratio
1.69
Price-to-FCF
23.37
Gross Margin
29.09%
Net Margin
4.11%
Revenue Growth (YoY)
43.02%
Profit Growth (YoY)
56.41%
3-Year Revenue Growth
8.71%
3-Year Profit Growth
31.35%

  • When is KEQU's latest earnings report released?

    The most recent financial report for Kewaunee scientific corporation (KEQU) covers the period of 2026Q2 and was published on 2025/10/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating KEQU's short-term business performance and financial health. For the latest updates on KEQU's earnings releases, visit this page regularly.

  • Where does KEQU fall in the P/E River chart?

    According to historical valuation range analysis, Kewaunee scientific corporation (KEQU)'s current price-to-earnings (P/E) ratio is 9.22, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of KEQU?

    According to the latest financial report, Kewaunee scientific corporation (KEQU) reported an Operating Profit of 4.11M with an Operating Margin of 5.86% this period, representing a decline of 7.37% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is KEQU's revenue growth?

    In the latest financial report, Kewaunee scientific corporation (KEQU) announced revenue of 70.1M, with a Year-Over-Year growth rate of 46.75%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does KEQU have?

    As of the end of the reporting period, Kewaunee scientific corporation (KEQU) had total debt of 73.73M, with a debt ratio of 0.39. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does KEQU have?

    At the end of the period, Kewaunee scientific corporation (KEQU) held Total Cash and Cash Equivalents of 13.68M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does KEQU go with three margins increasing?

    In the latest report, Kewaunee scientific corporation (KEQU) achieved the “three margins increasing” benchmark, with a gross margin of 28.1%%, operating margin of 5.86%%, and net margin of 3.5%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess KEQU's profit trajectory and future growth potential.

  • Is KEQU's EPS continuing to grow?

    According to the past four quarterly reports, Kewaunee scientific corporation (KEQU)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.85. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of KEQU?

    Kewaunee scientific corporation (KEQU)'s Free Cash Flow (FCF) for the period is -5.84M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 175.26% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.